|
|
|
市場調查報告書
|
全球代謝組學市場 是由出版商Global Industry Analysts, Inc.在2011年08月所出版的。
這份英文市場調查報告書包含Pages: 287 價格從美金4500起跳。
本報告書為全球代謝學市場的相關調査分析、代謝學業界概要與產品技術革新動向等概說，同時包含全球主要各地區的動向、以及相關企業的簡介，概述如下。
第1章 導論、調査方法、產品定義
第2章 業界概要
- 今後的前景
- 現狀與將來分析
- 生物科技與醫藥品部門促進了代謝學研究
- 代謝學：創藥中的便利工具
- 代謝學研究：驗證潛在標的的有潛力的工具
- 生物資訊區段：最快速擴大的市場分類
- 數據分析工具與軟體需求增大
- 促進代謝學的導入的劃時代的成功
- 代謝學研究：在歐洲的熱門概念
- 食品科學關注著代謝學
- 生物學的標本應用之代謝學分析
- 針對生物標記創藥的代謝學資料建立
第3章 產品概要
- 代謝學：導論
- 代謝學與代謝
- 分析方法
- 主要應用領域
- 代謝學之概念性方法
- 技術的進歩
- 做為系統生物學工具的代謝學
- 基因學與生態學間的關係
- 代謝學研究的外洋
- 代謝學研究的相關課題
- 歷史
第4章 產品導入・技術革新
第5章 近年業界活動
第6章 主要企業
- Agilent Technologies, Inc.
- Avogadro
- BG Medicine, Inc.
- Biocrates Life Sciences AG
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Chenomx, Inc.
- Human Metabolome Technologies, Inc.
- Metabolon, Inc.
- Metanomics GmbH
- SiDMAP, LLC
第7章 世界市場前景
第8章 美國
第9章 加拿大
第10章 日本
第11章 歐洲
第12章 亞太地區
第13章 其他地區
企業簡介：45家
Abstract
This report analyzes the worldwide markets for Metabolomics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Acia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2008 through 2017. The report profiles 45 companies including many key and niche players such as Agilent Technologies, Inc., Avogadro, BG Medicine, Inc., Biocrates Life Sciences AG, Bio-Rad Laboratories, Inc., Bruker Corporation, Chenomx, Inc., Human Metabolome Technologies, Inc., Metabolon, Inc., Metanomics GmbH, and SiDMaP, LLC. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Table of Contents
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
2. INDUSTRY OVERVIEW
- Outlook
- Current and Future Analysis
- Biotechnology and Pharmaceutical Sectors Drive Metabolomics Research
- Table 1: World Proteomics Market (2008 & 2015): Percentage Share
Breakdown by Major Product Segments - Mass Spectrometry, Metabolomics, 2D
Gel Electrophoresis and Differential In-gel Electrophoresis (includes
corresponding Graph/Chart)
- Metabolomics - A Handy Tool in Drug Discovery
- Metabolomic Research - A Prospective Tool to Validate Potential Targets
- Bioinformatics Segment - Fastest Growing Market Segment
- Demand for Data Analysis Tools and Software on Rise
- Groundbreaking Successes to Propel Adoption of Metabolomics
- Metabolomic Research - A Popular Concept in Europe
- Food Sciences Look Up to Metabolomics
- Metabolites Analysis in Biological Specimens Applications
- Table 2: Global Metabolites Market (2010 & 2014): Percentage
Breakdown of Revenues in Biological Specimens Applications by Region - North
America, Europe, Asia, and Rest of World (includes corresponding
Graph/Chart)
- Metabolite Profiling for Biomarker Discovery Applications
- Table 3: Global Metabolite Profiling Market (2010 & 2014):
Percentage Breakdown of Revenues in Biomarker Discovery Applications by
Region - North America, Europe, Asia, and Rest of World (includes
corresponding Graph/Chart)
- Table 4: Worldwide Oncology Biomarker Discovery Market (2010):
Percentage Share Breakdown by Major Segments -Genetic, Imaging, Protein and
Metabolomics (includes corresponding Graph/Chart)
3. PRODUCT OVERVIEW
- Metabolomics - Introduction
- Metabolomics Vs. Metabonomics
- Analytical Methods
- Separation Techniques
- Gas chromatography
- Capillary Electrophoresis
- High Performance Liquid Chromatography (HPLC)
- Detection Techniques
- Mass spectrometry
- Nuclear Magnetic Resonance (NMR) Spectroscopy
- Surface-based Mass Analysis
- Key Application Areas
- Toxicity Assessment/Toxicology
- Functional Genomics
- Nutrigenomics
- Conceptual Approaches in Metabolomics
- Target Analysis
- Metabolite Profiling
- Metabolomics
- Metabolic Fingerprinting
- Technological Advancements in Metabolomics
- Metabolomics as Systems Biology Tool
- Metabolomics: A Link Between Genetics and Ecology
- Limitations
- An Overview of Metabolomics Research
- Adoption of Metabolomics Research by Type of Entity
- Implementation of Metabolomics Research by Nature of Study
- Implementation of Metabolomics Research by Type of Laboratory
- Key Issues Associated with Metabolomics Study
- History
4. PRODUCT INTRODUCTIONS/INNOVATIONS
- Food for Health Ireland Launches New Range of Metabolomics
- BIOCRATES Life Sciences Introduces AbsoluteIDQ p180 Kit
- BIOCRATES Life Sciences Rolls Out MetaDisIDQ Kit
- Agilent Technologies Rolls Out GeneSpring GX 11.5 Suite
- Thermo Fisher Scientific Introduces Version 7.0 of Mass Frontier Software
- Thermo Fisher Scientific Rolls Out ' MetQuest' Automated Metabolic
Screening Software
- Molecular Biometrics Launches ViaMetrics-ET Procedure
- Bruker Daltonics Introduces First 18 Tesla FTMS Magnet
- Agilent Technologies Launches 6540 UHD Q-TOF, 7700 Series ICP-MS and 6430
Triple Quadrupole LC/MS
- Bio-Rad Introduces Spectral Databases and KnowItAll® Informatics
System 8.1
- Bio-Rad Laboratories Launches Spectral Databases
- Agilent Technologies Unveils Agilent 6540 UHD Accurate-mass Q-TOF LC/MS
- Genedata Rolls Out Expressionist 5.2
- Bruker Daltonics Introduces New Ion Trap amaZon Series
- XenoTech Starts Providing Metabolite Profiling Services
5. RECENT INDUSTRY ACTIVITY
- Bruker Deploys NMR Metabolic Profiling Units Systems
- OWL Genomics Takes Over Majority Stake in MD Renal
- Symyx Technologies Inks Partnership with Simulations Plus
- BIOCRATES Life Sciences Joins SysKid
- BIOCRATES Life Sciences Signs Agreement with CHENOMX
- Stemina Biomarker Discovery Teams Up with Agilent Technologies
- Scottish Metabolomics Facility Selects Mass Spectrometers of Thermo
Fisher Scientific
- Syngenta Ventures Purchases Stake in Metabolon
- Horizon Discovery Inks Agreement with GlaxoSmithKline
- Rexahn Pharmaceuticals Signs Licensing Agreement with Teva Pharmaceutical
Industries
- Microsoft Takes Over Rosetta Biosoftware
- Dionex and ESA Biosciences Ink Agreement
- Agios Pharmaceuticals Discovers New Application of IDH1 Gene Mutation
6. FOCUS ON SELECT PLAYERS
- Agilent Technologies, Inc. (US)
- Avogadro (France)
- BG Medicine, Inc. (US)
- Biocrates Life Sciences AG (Austria)
- Bio-Rad Laboratories, Inc. (US)
- Bruker Corporation (US)
- Chenomx, Inc. (Canada)
- Human Metabolome Technologies, Inc. (Japan)
- Metabolon, Inc. (US)
- Metanomics GmbH (Germany)
- SiDMAP, LLC (US)
7. GLOBAL MARKET PERSPECTIVE
- Table 5: World Recent Past, Current and Future Analysis for
Metabolomics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(Excluding Japan), and Rest of World Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2008 through 2017 (includes
corresponding Graph/Chart)
- Table 6: World 10-Year Perspective for Metabolomics by Geographic
Region -Percentage Breakdown of Dollar Revenues for US, Canada, Japan, Europe,
Asia-Pacific (Excluding Japan), and Rest of World Markets for Years 2008, 2011
and 2017 (includes corresponding Graph/Chart)
8. THE UNITED STATES
- A. Market Analysis
- Current and Future Analysis
- Product Introductions/Innovations
- Recent Industry Activity
- Key Players
- B. Market Analytics
- Table 7: US Recent Past, Current & Future Analysis for
Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years
2008 through 2017 (includes corresponding Graph/Chart)
9. CANADA
- A. Market Analysis
- Current and Future Analysis
- Key Player
- B. Market Analytics
- Table 8: Canadian Recent Past, Current & Future Analysis for
Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years
2008 through 2017 (includes corresponding Graph/Chart)
10. JAPAN
- A. Market Analysis
- Current and Future Analysis
- Key Player
- B. Market Analytics
- Table 9: Japanese Recent Past, Current & Future Analysis for
Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years
2008 through 2017 (includes corresponding Graph/Chart)
11. EUROPE
- A. Market Analysis
- Current and Future Analysis
- Product Introductions/Innovations
- Recent Industry Activity
- B. Market Analytics
- Table 10: European Recent Past, Current & Future Analysis for
Metabolomics by Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets Independently Analyzed with Annual Revenues in US$ Million
for Years 2008 through 2017 (includes corresponding Graph/Chart)
- Table 11: European 10-year Perspective for Metabolomics by
Geographic Region - Percentage Breakdown of Dollar Revenues for France,
Germany, Italy, UK and Rest of Europe Markets for Years 2008, 2011 and 2017
(includes corresponding Graph/Chart)
11a. FRANCE
- A. Market Analysis
- Current and Future Analysis
- Key Player
- B. Market Analytics
- Table 12: French Recent Past, Current & Future Analysis for
Metabolomics Independently Analyzed with Annual Revenues in US$ Million for
Years 2008 through 2017 (includes corresponding Graph/Chart)
11b. GERMANY
- A. Market Analysis
- Current and Future Analysis
- Key Player
- B. Market Analytics
- Table 13: German Recent Past, Current & Future Analysis for
Metabolomics Independently Analyzed with Annual Revenues in US$ Million for
Years 2008 through 2017 (includes corresponding Graph/Chart)
11c. ITALY
- A. Market Analysis
- Current and Future Analysis
- B. Market Analytics
- Table 14: Italian Recent Past, Current & Future Analysis for
Metabolomics Independently Analyzed with Annual Revenues in US$ Million for
Years 2008 through 2017 (includes corresponding Graph/Chart)
11d. THE UNITED KINGDOM
- A. Market Analysis
- Current and Future Analysis
- B. Market Analytics
- Table 15: UK Recent Past, Current & Future Analysis for
Metabolomics Independently Analyzed with Annual Revenues in US$ Million for
Years 2008 through 2017 (includes corresponding Graph/Chart)
11e. REST OF EUROPE
- A. Market Analysis
- Current and Future Analysis
- Product Introductions/Innovations
- Recent Industry Activity
- Key Player
- B. Market Analytics
- Table 16: Rest of Europe Recent Past, Current & Future Analysis
for Metabolomics Independently Analyzed with Annual Revenues in US$ Million
for Years 2008 through 2017 (includes corresponding Graph/Chart)
12. ASIA-PACIFIC
- A. Market Analysis
- Current and Future Analysis
- B. Market Analytics
- Table 17: Asia-Pacific Recent Past, Current & Future Analysis
for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for
Years 2008 through 2017 (includes corresponding Graph/Chart)
13. REST OF WORLD
- A. Market Analysis
- Current and Future Analysis
- B. Market Analytics
- Table 18: Rest of World Recent Past, Current & Future Analysis
for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for
Years 2008 through 2017 (includes corresponding Graph/Chart)
COMPETITIVE LANDSCAPE
|
 |
